Follow us on:
Breaking News
June 12, 2026
CP Direct: Friday Edition
Breaking News
Next Week at Contract Pharma
FederalEquipment_Webinar_06-16-26_NextWeek@

The Friday Brief for June 12, 2026: Billions Bet on Pharma Acquisitions

 
The Friday Brief for June 12, 2026: Billions Bet on Pharma Acquisitions

GSK and J&J announce big buyouts, while other partnerships expand footprints and further R&D.
Watch Now >>

Top Headlines

Breaking News

Chiesi Group Acquires KalVista Pharmaceuticals for $1.9B

KalVista will contribute to the growth of Chiesi’s Rare Diseases business unit.

SPONSOR

Need help selecting the right modified release OSD platform?

Discover practical guidance on formulation design, process control, and scaling strategies for complex modified-release programs.

Breaking News

Cytovance Biologics Adds Cell Line Development Services

Strengthens its ability to provide a seamless path from DNA to IND submission for its customers.

Breaking News

Axplora to Consolidate UDCA Manufacturing at Vizag, India Site by End of 2026

Production is transitioning from Gropello Cairoli, Italy, within the Farmabios business unit.

SPONSOR

[VIDEO] The Importance of High-Purity DMSO for Today’s Pharmaceuticals

Nigel Langley of gChem discusses the advantages of its high-purity Dimethyl sulfoxide in pharmaceutical applications.

GlobalInsightConference_Enl_052026_650x250

Breaking News
Collaborations & Alliances

AmMax Bio, Lonza Enter Non-Exclusive Licensing Agreement for AMB-104

AMB-104 provides a unique solution to address venetoclax/azacitidine resistance in acute myeloid leukemia (AML).

Expert’s Opinion

3 Clinical Trial Rebound Trends – And How to Scale Smoothly

Phase II starts are increasing the fastest of all clinical phases, trials are running leaner, and the safety data challenge is growing.

Featured Resources

Solution Center SPOTLIGHT

Abzena

Abzena is the leading end-to-end bioconjugate (ADC, AOC, & RDC) & complex biologics CDMO + CRO. From discovery through commercial, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development and manufacture of new treatments for patients. Let us help move your program forward faster.

 

Solution Center SPOTLIGHT

UI Pharmaceuticals

UI Pharmaceuticals, an FDA-registered, university-affiliated pharmaceutical manufacturing facility, has been a trusted partner since 1974. We provide comprehensive development, manufacturing, and testing services for sterile solutions, lyophilized products, tablets, capsules, and other forms, ensuring quality, compliance, and client satisfaction.